Entera Bio's market cap is currently $77.35M. The company's EPS TTM is $-0.26; its P/E ratio is ―; Entera Bio is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 134.00K	$ 571.00K	$ 365.00K	$ 236.00K
Gross Profit	$ -56.00K	$ 33.00K	$ 198.00K	$ 156.00K	$ 26.00K
Operating Income	$ -8.89M	$ -13.02M	$ -12.22M	$ -11.13M	$ -11.45M
EBITDA	$ -8.80M	$ -12.87M	$ -12.16M	$ -11.11M	$ -11.35M
Net Income	$ -8.89M	$ -13.07M	$ -12.19M	$ -9.98M	$ -10.88M
Balance Sheet
Cash & Short-Term Investments	$ 11.02M	$ 12.31M	$ 24.89M	$ 8.59M	$ 15.19M
Total Assets	$ 11.77M	$ 13.13M	$ 25.99M	$ 10.26M	$ 16.70M
Total Debt	$ 390.00K	$ 91.00K	$ 302.00K	$ 432.00K	$ 299.00K
Net Debt	$ -10.63M	$ -12.22M	$ -24.59M	$ -8.16M	$ -14.89M
Total Liabilities	$ 1.38M	$ 1.37M	$ 3.42M	$ 3.60M	$ 4.78M
Stockholders' Equity	$ 10.39M	$ 11.75M	$ 22.57M	$ 6.67M	$ 11.92M
Cash Flow
Free Cash Flow	$ -7.33M	$ -12.55M	$ -9.08M	$ -10.48M	$ -8.96M
Operating Cash Flow	$ -7.31M	$ -12.50M	$ -9.06M	$ -10.42M	$ -8.92M
Investing Cash Flow	$ -17.00K	$ -102.00K	$ -17.00K	$ -86.00K	$ 3.95M
Financing Cash Flow	$ 6.04M	$ 13.00K	$ 25.38M	$ 3.92M	$ 12.65M

Currency in USD

Entera Bio Earnings and Revenue History

Income Statement >

Entera Bio Debt to Assets

Balance Sheet >

Entera Bio Cash Flow

Cash Flow >

Entera Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing